Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021;8(4):281-292.
doi: 10.1007/s40472-021-00343-0. Epub 2021 Oct 26.

Use of Organs from SARS-CoV-2 Infected Donors: Is It Safe? A Contemporary Review

Vivek B Kute  1 , Vidya A Fleetwood  2 , Hari Shankar Meshram  1 , Alexis Guenette  2 , Krista L Lentine  2
Affiliations
Review

Use of Organs from SARS-CoV-2 Infected Donors: Is It Safe? A Contemporary Review

Vivek B Kute et al. Curr Transplant Rep. 2021.

Abstract

Purpose of review: As the prevalence of individuals with recovered coronavirus disease 2019 (COVID-19) increases, determining if and when organs from these donors can be safely used is an important priority. We examined current knowledge of outcomes of transplant using donors with recovered COVID-19.

Recent findings: A literature search of PubMed and Google scholar databases was conducted to identify articles with terms "SARS-CoV2," "COVID-19," "donor recovered," and "transplantation" published through 08/10/2021. We identified 25 reports detailing 94 recipients of both abdominal and thoracic transplants from donors with both prior and active COVID-19 infection. Rates of transmission to the recipient and of transplanted organ dysfunction were low among reports of donors with prior COVID-19 infection. End organ dysfunction and transmission were more common with active infection, although few reports are available. Standardized reporting is needed to better assess the impact of donor symptomatology, cycle thresholds, and individual recipient risk factors on postoperative outcomes.

Summary: Available reports suggest that transplantation from COVID-19 donors may be feasible and safe, at least in short term follow-up. Nevertheless, there is a need for standardized testing and management protocols which should be tailored for available resources. While increased availability of COVID-19 vaccinations will mitigate risks of donor-derived COVID-19 and simplify management, continued vigilance is warranted during the ongoing public health emergency.

Keywords: COVID-19; Deceased donors; Living donors; Organ donation; Pandemic; SARS-CoV-2; Screening; Transplantation.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestThe authors declare no competing financial interests. K.L.L. is a member of the American Society of Nephrology (ASN) COVID-19 Response Team.

References

    1. Lentine KL, Mannon RB, Josephson MA. Practicing with uncertainty: kidney transplantation during the COVID-19 pandemic. Am J Kidney Dis. 2021;77(5):777–785. doi: 10.1053/j.ajkd.2020.12.003. - DOI - PMC - PubMed
    1. Boyarsky BJ, Werbel WA, Durand CM, et al. Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic. Am J Transplant. 2020;20(11):3131–3139. doi: 10.1111/ajt.16167. - DOI - PMC - PubMed
    1. Danziger-Isakov L, Blumberg EA, Manuel O, Sester M. Impact of COVID-19 in solid organ transplant recipients. Am J Transplant. 2021;21(3):925–937. doi: 10.1111/ajt.16449. - DOI - PMC - PubMed
    1. Loupy A, Aubert O, Reese PP, Bastien O, Bayer F, Jacquelinet C. Organ procurement and transplantation during the COVID-19 pandemic. Lancet. 2020;395(10237):e95–e96. doi: 10.1016/S0140-6736(20)31040-0. - DOI - PMC - PubMed
    1. Lentine KL, Singh N, Woodside KJ, et al. COVID-19 test result reporting for deceased donors: emergent policies, logistical challenges, and future directions. Clin Transplant. 2021;35(5):e14280. doi: 10.1111/ctr.14280. - DOI - PMC - PubMed

LinkOut - more resources